MedVest Fund One Portfolio Company Broadens Its Intellectual Property Portfolio with Allowance of Its Seventh U.S. Patent

Jupiter, Florida – Providence Medical Technology (PMT), a San Francisco Area medical device startup and Medvest Fund One portfolio company, today announced the issuance of its fifth U.S. patent in 12 months. This brings PMT’s portfolio of issued patents to seven.

The announcement further validates PMT’s focus on developing novel methods and instruments for minimally invasive delivery of an implant into the posterior cervical facet joint.

PMT’s full press release can be found here.

Providence Medical Technology is a privately held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical spine market.  For more information on Providence Medical Technology contact David Schummers at (415) 925-9376 or [email protected]

Medvest Fund One is an $8.0 million private equity fund targeting medical device and technology companies who are positioned for growth and share the Fund’s core values.  The Fund is accepting subscriptions.  For more information contact David Cash at (561) 459-3333 or [email protected]

Scroll to top